Professor and Chair of Urology
Urology
Dr. Johannes W. Vieweg, MD
|
|
Give Review
Johannes Vieweg works in the field of Urology. He received 10 awards: "Active Member", "The Wayne and Marti Eminent Scholar's Chair in Urologic Research", "21st Century World Scholar", "Endowed Scholar Chair Award", "Investigator Award", "Scholar in Urology Award", "Giovanni Di Chiro Award for Outstanding Scientific Research", "Research Scholar", "First Prize, Clinical Research Award" and "Fellow (FACS)". Doctor Johannes W. Vieweg, MD is also a published doctor. He has 93 paper published. The most recent paper is: Pelvic lymph node dissection can be curative in patients with node positive bladder cancer.
Publications
- Clinical Practice Guidelines on Prostate Cancer: A Critical Appraisal.
- Expansion of CCR8+ inflammatory myeloid cells in Cancer patients with urothelial and renal carcinomas.
- Trifecta Nerve Complex - Potential Anatomic Basis for Microsurgical Denervation of the Spermatic Cord for Chronic Orchialgia.
- Cell-based selection provides novel molecular probes for Cancer stem cells.
- Prostate Cancer: targeting complexity.
- A tribute to the life and accomplishments of Birdwell Finlayson.
- Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge Conference.
- Apical soft tissue biopsies predict biochemical failure in radical perineal prostatectomy patients with apical Cancer involvement.
- Female fertility following extracorporeal shock wave lithotripsy of distal ureteral calculi.
- [Primary management of fresh injuries of the thoracic and lumbar vertebrae].
- [Intra- and postoperative morbidity of radical Prostatectomy].
- [Validity of nuclear magnetic resonance tomography in evaluation of the traumatized intervertebral disk].
- [Post-ischemia normal function of living related Kidney transplants after preservation with HTK solution].
- Piroximone, dobutamine and nitroprusside: comparative effects on haemodynamics in patients with congestive heart failure.
- [A new concept in teaching First Aid. Questioning shows: education according to the care-centered first aid concept is judged positively].
- Immunotherapy of Cancer using cytokine gene-modified tumor vaccines.
- Efficient gene transfer with adeno-associated virus-based plasmids complexed to cationic liposomes for gene therapy of human prostate Cancer.
- Gene therapy approaches in urologic oncology.
- Considerations for the use of cytokine-secreting tumor cell preparations for Cancer treatment.
- Immunotherapy of prostate Cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines.
- The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive Bladder cancer. The Memorial Sloan-Kettering Cancer Center experience.
- An experimental model simulating local recurrence and pelvic lymph node metastasis following orthotopic induction of prostate Cancer.
- [Cardiopulmonary resuscitation].
- [Basic principles of gene therapy].
- Does prostate transitional cell carcinoma preclude orthotopic Bladder reconstruction after radical cystoprostatectomy for Bladder cancer?
- Urolithiasis: detection and management with unenhanced spiral CT--a urologic perspective.
- Unenhanced helical computerized tomography for the evaluation of patients with acute flank pain.
- Transient lower extremity neurapraxia associated with radical perineal Prostatectomy: a complication of the exaggerated lithotomy position.
- Interobserver variability in the interpretation of unenhanced helical CT for the diagnosis of ureteral stone disease.
- Pelvic lymph node dissection can be curative in patients with node positive Bladder cancer.
- The impact of primary stage on survival in patients with lymph node positive Bladder cancer.
- Human dendritic cells transfected with RNA encoding Prostate-specific antigen stimulate Prostate-specific CTL responses in vitro.
- Outcome analysis in patients with primary necrotizing fasciitis of the male genitalia.
- Radical cystectomy for invasive Bladder cancer: contemporary results and remaining controversies.
- The evolving role of dendritic cell therapy in urologic oncology.
- Outcome profiles of locoregional disease after radical Prostatectomy and radiotherapy.
- Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.
- Induction of polyclonal prostate Cancer-specific CTL using dendritic cells transfected with amplified tumor RNA.
- Comparison of ultrasound-guided biopsies and Prostatectomy specimens: predictive accuracy of Gleason score and tumor site.
- Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against Antigens expressed by primary and metastatic tumors.
- Radical perineal Prostatectomy: a model for evaluating local response of Prostate therapy.
- Enhanced induction of telomerase-Specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product.
- Synergy between tumor immunotherapy and antiangiogenic therapy.
- Immunological and clinical responses in metastatic renal Cancer patients vaccinated with tumor RNA-transfected dendritic cells.
- A longitudinal assessment of bowel related symptoms and fecal incontinence following radical perineal Prostatectomy.
- Tumor vaccines: from gene therapy to dendritic cells--the emerging frontier.
- Prospective evaluation of pain medication requirements and recovery after radical perineal Prostatectomy.
- When to diagnose and how to treat prostate Cancer in the "not too fit" elderly.
- Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation.
- Urinary continence and quality of life in the first year after radical perineal Prostatectomy.
- Immunotherapy of surgical malignancies.
- Induction of human dendritic cell maturation using transfection with RNA encoding a dominant positive toll-like receptor 4.
- Prospective and longitudinal patient self-assessment of health-related quality of life following radical perineal Prostatectomy.
- Cancer immunotherapy with mRNA-transfected dendritic cells.
- Antigenic targets for renal cell carcinoma immunotherapy.
- Modulation of antitumor responses by dendritic cells.
- Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand.
- Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate Cancer.
- Can outpatient interleukin-2 and interferon replace high-dose interleukin-2 for metastatic renal cell carcinoma?
- Enhancement of vaccine-mediated antitumor immunity in Cancer patients after depletion of regulatory T cells.
- Technology Insight: vaccine therapy for prostate Cancer.
- Radical perineal prostatectomy for treatment of localized prostate Cancer in obese and nonobese patients: a matched control study.
- Future directions for vaccine-based therapies.
- Vaccines in renal cell carcinoma.
- Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma.
- Evaluating the evidence: statistical methods in randomized controlled trials in the urological literature.
- Differentiation of human embryonic stem cells into immunostimulatory dendritic cells under feeder-free culture conditions.
- Evaluating the evidence: the methodological and reporting quality of comparative observational studies of surgical interventions in urological publications.
- Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma.
- Altered expression of 15-hydroxyprostaglandin dehydrogenase in tumor-infiltrated CD11b myeloid cells: a mechanism for immune evasion in Cancer.
- Duplicate presentations on prostate Cancer at American Urological Association and European Association of Urology annual meetings.
- Enhancing the efficacy of Cancer vaccines in urologic oncology: new directions.
- A novel DNMT3B splice variant expressed in tumor and pluripotent cells modulates genomic DNA methylation patterns and displays altered DNA binding.
- Generation of Antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2''-deoxycytidine.
- Expression of pluripotent stem cell reprogramming factors by Prostate tumor initiating cells.
- Reporting quality and information consistency of randomized, controlled trials presented as absTracts at the American Urological Association annual meetings.
- Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE? catabolism in myeloid cells.
- Screening for prostate Cancer: systematic review and meta-analysis of randomised controlled trials.
- Aberrant PGE₂ metabolism in Bladder tumor microenvironment promotes immunosuppressive phenotype of tumor-infiltrating myeloid cells.
- Circulating and tumor-infiltrating myeloid cell subsets in patients with Bladder cancer.
- Tumor-associated macrophages mediate immunosuppression in the renal Cancer microenvironment by activating the 15-lipoxygenase-2 pathway.
- Combination Therapy for Renal Cell Cancer: What Are Possible Options?
- Autologous dendritic cells transfected with Prostate-specific antigen RNA stimulate CTL responses against metastatic Prostate tumors.
- Reversal of tumor-mediated immunosuppression.
- Factors associated with the full publication of studies presented in absTract form at the annual meeting of the American Urological Association.
- A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature.
- The role of early adopter bias for new technologies in robot assisted laparoscopic Prostatectomy.
- Immunotherapy for advanced prostate Cancer.
- The evolving therapeutic landscape of prostate Cancer.
- Impact of nerve sparing technique on patient self-assessed outcomes after radical perineal Prostatectomy.
- Levels of evidence in the urological literature.
- Study characteristics of absTracts presented at the annual meetings of the southeastern section of the American Urological Association (1996-2005).
Procedures Preformed
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- TURP (Transurethral Resection of Prostate) or Laser Destruction of Prostate
Conditions Treated
- Bladder Cancer
- Blood in Urine (Hematuria)
- Chronic Kidney Diseases
- Elevated PSA (Prostate Specific Antigen)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- Active Member
- The Wayne and Marti Eminent Scholar's Chair in Urologic Research
- 21st Century World Scholar
- Endowed Scholar Chair Award
- Investigator Award
- Scholar in Urology Award
- Giovanni Di Chiro Award for Outstanding Scientific Research
- Research Scholar
- First Prize, Clinical Research Award
- Fellow (FACS)
Education
-
Duke University Hospital -
Memorial Sloan-Kettering Cancer Center -
Technical University Munich Faculty of Medicine
Hospital
-
UF Health Shands Hospital -
Orlando Regional Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Li-Ming Su, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Daryl B. Bullen, MD |
|
|
Dr. Robert C. Newman, MD |
|
|
Dr. Thomas F. Stringer, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Martin N. Rifkin, MD |
|
|
Dr. Stephen L. Deardourff, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Cristoforo L. Cama, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Binder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph H. Ellen III, MD |
|
|
Dr. Rishi A. Modh, MD
This Doctor is OpenDoctor Recommended.
|